Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
423,589
+229,524
+118% +$6M 0.03% 272
2026
Q1
$5.45M Buy
194,065
+32,573
+20% +$867K 0.03% 254
2025
Q4
$4.02M Sell
161,492
-12,303
-7% -$310K 0.02% 279
2025
Q3
$4.43M Buy
173,795
+15,095
+10% +$373K 0.03% 252
2025
Q2
$3.85M Sell
158,700
-4,025
-2% -$93.9K 0.03% 247
2025
Q1
$4.12M Sell
162,725
-71,804
-31% -$1.88M 0.03% 216
2024
Q4
$6.22M Sell
234,529
-17,961
-7% -$487K 0.05% 211
2024
Q3
$7.31M Buy
252,490
+34,005
+16% +$992K 0.06% 176
2024
Q2
$6.11M Sell
218,485
-13,851
-6% -$381K 0.06% 184
2024
Q1
$6.45M Buy
232,336
+18,915
+9% +$525K 0.07% 163
2023
Q4
$6.14M Sell
213,421
-8,077
-4% -$244K 0.08% 162
2023
Q3
$7.35M Buy
221,498
+2,489
+1% +$88K 0.11% 136
2023
Q2
$8.03M Buy
219,009
+76,231
+53% +$2.97M 0.13% 121
2023
Q1
$5.83M Sell
142,778
-38,068
-21% -$1.64M 0.11% 129
2022
Q4
$5.39M Buy
180,846
+84,610
+88% +$4.06M 0.13% 90
2022
Q3
$4.21M Buy
96,236
+1,719
+2% +$83.5K 0.13% 97
2022
Q2
$4.96M Buy
94,517
+3,431
+4% +$175K 0.15% 83
2022
Q1
$4.72M Buy
91,086
+829
+0.9% +$43K 0.15% 79
2021
Q4
$5.33M Buy
90,257
+5,289
+6% +$262K 0.17% 72
2021
Q3
$3.65M Buy
84,968
+10,266
+14% +$455K 0.13% 87
2021
Q2
$2.92M Buy
74,702
+7,978
+12% +$310K 0.12% 97
2021
Q1
$2.42M Buy
66,724
+217
+0.3% +$7.71K 0.13% 103
2020
Q4
$2.45M Sell
66,507
-4,883
-7% -$179K 0.14% 101
2020
Q3
$2.49M Sell
71,390
-714
-1% -$25K 0.17% 95
2020
Q2
$2.24M Sell
72,104
-4,520
-6% -$154K 0.17% 100
2020
Q1
$2.37M Buy
76,624
+12,667
+20% +$432K 0.23% 85
2019
Q4
$2.38M Buy
63,957
+988
+2% +$35.2K 0.29% 81
2019
Q3
$2.15M Buy
62,969
+1,468
+2% +$53.4K 0.3% 77
2019
Q2
$2.53M Buy
61,501
+124
+0.2% +$4.92K 0.36% 66
2019
Q1
$2.47M Buy
61,377
+484
+0.8% +$19.4K 0.46% 53
2018
Q4
$2.52M Sell
60,893
-939
-2% -$39K 0.53% 51
2018
Q3
$2.58M Buy
61,832
+160
+0.3% +$6.16K 0.46% 46
2018
Q2
$2.12M Buy
61,672
+1,403
+2% +$47.9K 0.45% 47
2018
Q1
$2.03M Buy
60,269
+2,361
+4% +$81.2K 0.43% 47
2017
Q4
$1.99M Buy
57,908
+2,424
+4% +$82.7K 0.42% 47
2017
Q3
$1.88M Buy
55,484
+388
+0.7% +$12.5K 0.42% 42
2017
Q2
$1.76M Sell
55,096
-2,648
-5% -$83.5K 0.41% 43
2017
Q1
$1.87M Buy
57,744
+3,416
+6% +$108K 0.46% 40
2016
Q4
$1.67M Sell
54,328
-2,286
-4% -$69.8K 0.45% 42
2016
Q3
$1.82M Sell
56,614
-4,199
-7% -$140K 0.5% 36
2016
Q2
$2.03M Sell
60,813
-946
-2% -$30.2K 0.58% 33
2016
Q1
$1.74M Sell
61,759
-5,919
-9% -$169K 0.53% 34
2015
Q4
$2.07M Buy
67,678
+6,410
+10% +$202K 0.65% 31
2015
Q3
$1.83M Buy
61,268
+4,451
+8% +$143K 0.65% 30
2015
Q2
$1.81M Buy
56,817
+1,038
+2% +$33.8K 0.61% 28
2015
Q1
$1.84M Sell
55,779
-602
-1% -$19.1K 0.65% 25
2014
Q4
$1.67M Buy
56,381
+5,567
+11% +$160K 0.63% 28
2014
Q3
$1.43M Sell
50,814
-125
-0.2% -$3.51K 0.61% 33
2014
Q2
$1.43M Sell
50,939
-72
-0.1% -$2.05K 0.62% 29
2014
Q1
$1.55M Buy
51,011
+1,441
+3% +$43K 0.72% 26
2013
Q4
$1.44M Sell
49,570
-186
-0.4% -$5.41K 0.71% 29
2013
Q3
$1.36M Sell
49,756
-2,331
-4% -$63.4K 0.74% 26
2013
Q2
$1.38M Buy
+52,087
New +$1.44M 0.8% 25

Other funds holding PFE

Savant Capital's PFE Position: Q2 2026 in Review

Savant Capital increased its Pfizer (PFE) stake by 118% in Q2 2026, buying an estimated $6M and bringing the position to 423,589 shares worth $11M. The position accounts for 0.03% of the portfolio, ranked #272.

Savant Capital first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Savant Capital held 423,589 shares of Pfizer worth $11M as of Q2 2026.
  • Savant Capital bought 229,524 Pfizer shares in Q2 2026, an estimated $6M.
  • Pfizer made up 0.03% of Savant Capital's portfolio in Q2 2026, its #272 holding.
  • Savant Capital first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.